Jim Simons Bicycle Therapeutics PLC Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Renaissance Technologies LLC holds 272,600 shares of BCYC stock, worth $6.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

272,600

Previous 326,800 16.59%

Holding current value

$6.33 Million

Previous $6.61 Million 6.53%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$19.58 - $27.24 $1.06 Million - $1.48 Million	-54,200 Reduced 16.59%	272,600 $6.18 Million
Q2 2024 Aug 09, 2024	BUY	$20.02 - $24.69 $3.23 Million - $3.98 Million	161,100 Added 97.22%	326,800 $6.61 Million
Q1 2024 May 13, 2024	BUY	$16.75 - $26.1 $1.01 Million - $1.57 Million	60,200 Added 57.06%	165,700 $4.13 Million
Q4 2023 Feb 13, 2024	BUY	$13.29 - $22.2 $312,315 - $521,700	23,500 Added 28.66%	105,500 $1.91 Million
Q3 2023 Nov 14, 2023	BUY	$19.9 - $26.25 $220,889 - $291,375	11,100 Added 15.66%	82,000 $1.65 Million
Q2 2023 Aug 11, 2023	BUY	$18.95 - $28.67 $170,550 - $258,030	9,000 Added 14.54%	70,900 $1.81 Million
Q1 2023 May 12, 2023	BUY	$20.02 - $31.37 $1.24 Million - $1.94 Million	61,900 New	61,900 $1.32 Million
Q2 2022 Aug 12, 2022	BUY	$12.95 - $46.99 $1.15 Million - $4.17 Million	88,801 Added 137.89%	153,200 $2.57 Million
Q1 2022 May 13, 2022	SELL	$40.12 - $59.5 $352,253 - $522,410	-8,780 Reduced 12.0%	64,399 $2.83 Million
Q4 2021 Feb 11, 2022	BUY	$41.7 - $61.14 $3.05 Million - $4.47 Million	73,179 New	73,179 $4.45 Million
Q3 2021 Nov 12, 2021	SELL	$27.95 - $44.24 $408,070 - $645,904	-14,600 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$27.0 - $32.28 $329,400 - $393,816	-12,200 Reduced 45.52%	14,600 $443,000
Q1 2021 May 13, 2021	SELL	$19.12 - $30.25 $1.04 Million - $1.65 Million	-54,400 Reduced 67.0%	26,800 $801,000
Q4 2020 Feb 10, 2021	BUY	$17.95 - $21.36 $389,515 - $463,512	21,700 Added 36.47%	81,200 $1.46 Million
Q3 2020 Nov 13, 2020	SELL	$15.3 - $20.8 $232,560 - $316,160	-15,200 Reduced 20.35%	59,500 $1.13 Million
Q2 2020 Aug 13, 2020	BUY	$12.63 - $18.21 $706,017 - $1.02 Million	55,900 Added 297.34%	74,700 $1.18 Million
Q1 2020 May 14, 2020	BUY	$9.82 - $18.0 $184,616 - $338,400	18,800 New	18,800 $257,000

Others Institutions Holding BCYC

# of Institutions

113

Shares Held

41.3M

Call Options Held

3.4K

Put Options Held

12.4K

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $689M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account